首页 > 最新文献

Glavvrač (Chief Medical Officer)最新文献

英文 中文
Organization of air medical service in the Republic of Crimea 克里米亚共和国空中医疗服务组织
Pub Date : 2022-09-27 DOI: 10.33920/med-03-2210-01
O. M. Lyulko, A. Shvets, V. I. Zolotareva, S. S. Olefirenko
The article presents an analysis of the activities of the Department of Emergency Advisory Medical Care and Medical Evacuation of the Territorial Center of Disaster Medicine of the Republic of Crimea for the period 2019–2021 in the issues of sanitary and aviation evacuation of patients, as well as victims in emergency situations. In general, over the past three years, 207–238 departures have been carried out annually with the transportation of 203–258 patients by one full-time aviation resuscitation team of the Territorial Center of Disaster Medicine with the involvement of other specialists, if necessary. For the first time, the feature of professional activity in the «flight crew — aviation medical team» system is revealed. The training of the aircraft crew (pilot, navigator) on the basics of medical evacuation is proposed. Also, in order to optimize the activities of the specialists in aviation medical teams during the flight, it is recommended to conduct instructor trainings and simulators on the rules of operation of on-board medical equipment on the ground.
文章分析了克里米亚共和国领土灾难医学中心紧急咨询医疗护理和医疗后送司2019-2021年期间在病人和紧急情况下受害者的卫生和航空后送问题上的活动。总的来说,在过去三年中,由领土灾害医学中心的一个全职航空复苏小组每年进行207-238次撤离,运送203-258名病人,必要时还有其他专家参与。首次揭示了“飞行机组-航空医疗队”系统中专业活动的特点。建议对机组人员(飞行员、领航员)进行基本医疗后送培训。此外,为了优化航空医疗队专家在飞行期间的活动,建议在地面就机载医疗设备的操作规则进行教员培训和模拟。
{"title":"Organization of air medical service in the Republic of Crimea","authors":"O. M. Lyulko, A. Shvets, V. I. Zolotareva, S. S. Olefirenko","doi":"10.33920/med-03-2210-01","DOIUrl":"https://doi.org/10.33920/med-03-2210-01","url":null,"abstract":"The article presents an analysis of the activities of the Department of Emergency Advisory Medical Care and Medical Evacuation of the Territorial Center of Disaster Medicine of the Republic of Crimea for the period 2019–2021 in the issues of sanitary and aviation evacuation of patients, as well as victims in emergency situations. In general, over the past three years, 207–238 departures have been carried out annually with the transportation of 203–258 patients by one full-time aviation resuscitation team of the Territorial Center of Disaster Medicine with the involvement of other specialists, if necessary. For the first time, the feature of professional activity in the «flight crew — aviation medical team» system is revealed. The training of the aircraft crew (pilot, navigator) on the basics of medical evacuation is proposed. Also, in order to optimize the activities of the specialists in aviation medical teams during the flight, it is recommended to conduct instructor trainings and simulators on the rules of operation of on-board medical equipment on the ground.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129260106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of patient satisfaction with the results of hip replacement surger y based on the content analysis of Internet platforms data 基于互联网平台数据内容分析的髋关节置换术患者结果满意度分析
Pub Date : 2022-09-27 DOI: 10.33920/med-03-2210-06
N. Khudoshin, I. A. Khudoshin
The article is devoted to the issue of having a certain group of patients dissatisfied with the results of hip replacement surgery. Based on the content analysis of data from Internet platforms, the authors prove the presence of such a group among patients. That being said, the authors of the article emphasize the fact of the general neutrality of the vast majority of messages, which confirms the high level of satisfaction with the results of surgical treatmen.
这篇文章是专门讨论有一组患者对髋关节置换术的结果不满意的问题。通过对互联网平台数据的内容分析,作者证明了患者中存在这样一个群体。话虽如此,文章的作者强调了绝大多数信息的一般中立性,这证实了对手术治疗结果的高度满意度。
{"title":"Analysis of patient satisfaction with the results of hip replacement surger y based on the content analysis of Internet platforms data","authors":"N. Khudoshin, I. A. Khudoshin","doi":"10.33920/med-03-2210-06","DOIUrl":"https://doi.org/10.33920/med-03-2210-06","url":null,"abstract":"The article is devoted to the issue of having a certain group of patients dissatisfied with the results of hip replacement surgery. Based on the content analysis of data from Internet platforms, the authors prove the presence of such a group among patients. That being said, the authors of the article emphasize the fact of the general neutrality of the vast majority of messages, which confirms the high level of satisfaction with the results of surgical treatmen.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128082702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of combined antibacterial therapy in young children 幼儿联合抗菌药物治疗分析
Pub Date : 2022-09-27 DOI: 10.33920/med-03-2210-02
O. Eshonkhuzhaev, F.T. Usmanova
The aim of the work was to study the rationality and safety of combined antibiotic therapy in young children with bronchopneumonia. Methods: retrospective, descriptive study.
本研究旨在探讨小儿支气管肺炎联合抗生素治疗的合理性和安全性。方法:回顾性、描述性研究。
{"title":"Analysis of combined antibacterial therapy in young children","authors":"O. Eshonkhuzhaev, F.T. Usmanova","doi":"10.33920/med-03-2210-02","DOIUrl":"https://doi.org/10.33920/med-03-2210-02","url":null,"abstract":"The aim of the work was to study the rationality and safety of combined antibiotic therapy in young children with bronchopneumonia. Methods: retrospective, descriptive study.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"9 16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121676275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cases of mucormycosis in the Kazan Republican Clinical Hospital 喀山共和国临床医院毛霉菌病病例分析
Pub Date : 2022-08-31 DOI: 10.33920/med-03-2209-01
L. Kulagina, A. Kurbanov
Mucormycosis is a rare fungal infection with high morbidity and mortality in immunocompromised patients. Eight cases of mucormycosis were detected in the Kazan Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan: 5 men and 3 women, aged 22 to 70. Given the presence of patient risk factors, such as diabetes mellitus, recent novel coronavirus infection, and systemic glucocorticosteroid therapy, one can assume their influence on the development of mucormycosis in these patients.
毛霉病是一种罕见的真菌感染,在免疫功能低下的患者中具有很高的发病率和死亡率。在鞑靼斯坦共和国卫生部喀山共和国临床医院发现了8例毛霉病:5男3女,年龄22至70岁。考虑到患者危险因素的存在,如糖尿病、近期新型冠状病毒感染和全身糖皮质激素治疗,我们可以假设它们对这些患者毛霉病的发展有影响。
{"title":"Cases of mucormycosis in the Kazan Republican Clinical Hospital","authors":"L. Kulagina, A. Kurbanov","doi":"10.33920/med-03-2209-01","DOIUrl":"https://doi.org/10.33920/med-03-2209-01","url":null,"abstract":"Mucormycosis is a rare fungal infection with high morbidity and mortality in immunocompromised patients. Eight cases of mucormycosis were detected in the Kazan Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan: 5 men and 3 women, aged 22 to 70. Given the presence of patient risk factors, such as diabetes mellitus, recent novel coronavirus infection, and systemic glucocorticosteroid therapy, one can assume their influence on the development of mucormycosis in these patients.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128415331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Multitarget therapy (use of dietary supplement «Tummy Ease») in the treatment of functional bowel diseases 多靶点治疗(使用膳食补充剂«Tummy Ease»)治疗功能性肠病
Pub Date : 2022-08-31 DOI: 10.33920/med-03-2209-12
O. Minushkin, L. V. Maslovskiy, A. Frolova, T. Shindina, M. I. Bulanova, K. S. Legkova
Purpose: to evaluate the efficacy and safety of the Tummy Ease dietary supplement in the treatment of patients with functional constipation and IBS with a predominance of constipation.
目的:评价Tummy Ease膳食补充剂治疗以便秘为主的功能性便秘和IBS患者的疗效和安全性。
{"title":"Multitarget therapy (use of dietary supplement «Tummy Ease») in the treatment of functional bowel diseases","authors":"O. Minushkin, L. V. Maslovskiy, A. Frolova, T. Shindina, M. I. Bulanova, K. S. Legkova","doi":"10.33920/med-03-2209-12","DOIUrl":"https://doi.org/10.33920/med-03-2209-12","url":null,"abstract":"Purpose: to evaluate the efficacy and safety of the Tummy Ease dietary supplement in the treatment of patients with functional constipation and IBS with a predominance of constipation.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126131220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selected pharmacological effects of glycine 甘氨酸的选定药理作用
Pub Date : 2022-08-31 DOI: 10.33920/med-03-2209-14
Е. Chupakhina, M. Maksimov
Glycine is an aliphatic non-essential amino acid that performs a number of very diverse functions, forms part of proteins and such vital substances as collagen and glutathione, participates in the synthesis of heme porphyrin rings and nucleic acids, and performs the function of an inhibitory neurotransmitter in the central nervous system.
甘氨酸是一种脂肪族非必需氨基酸,具有多种功能,是蛋白质和胶原蛋白、谷胱甘肽等重要物质的组成部分,参与血红素卟啉环和核酸的合成,在中枢神经系统中起抑制神经递质的作用。
{"title":"Selected pharmacological effects of glycine","authors":"Е. Chupakhina, M. Maksimov","doi":"10.33920/med-03-2209-14","DOIUrl":"https://doi.org/10.33920/med-03-2209-14","url":null,"abstract":"Glycine is an aliphatic non-essential amino acid that performs a number of very diverse functions, forms part of proteins and such vital substances as collagen and glutathione, participates in the synthesis of heme porphyrin rings and nucleic acids, and performs the function of an inhibitory neurotransmitter in the central nervous system.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"103 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132392817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of the efficacy and safety of PCSK9 inhibitors in the therapy of lipid metabolism disorders PCSK9抑制剂治疗脂质代谢紊乱的疗效和安全性综述
Pub Date : 2022-08-31 DOI: 10.33920/med-03-2209-07
E. V. L. E. V. Lomakin
Lipid metabolism disorder with a predominance of very-low-density lipoproteins (VLDL), triglycerides (TG), and cholesterol (CS) in the blood plasma contributes to the development of atherosclerotic diseases, which to date remain the main cause of death among the population, ranking first among all causes of death in the world and claiming the lives of 4 million Earth inhabitants every year. In this regard, there is a need to search for drugs that reduce the level of cholesterol, triglycerides, and VLDL in blood plasma. Such a group of drugs is PCSK9 inhibitors. Purpose of the study: to evaluate the efficacy and safety of the new class of lipid-lowering drugs — PCSK9 inhibitors.
血浆中以极低密度脂蛋白(VLDL)、甘油三酯(TG)和胆固醇(CS)为主的脂质代谢紊乱有助于动脉粥样硬化性疾病的发展,动脉粥样硬化性疾病迄今仍是人口死亡的主要原因,在世界上所有死亡原因中排名第一,每年夺去400万地球居民的生命。在这方面,有必要寻找降低血浆中胆固醇、甘油三酯和VLDL水平的药物。这组药物就是PCSK9抑制剂。本研究目的:评价一类新型降脂药物PCSK9抑制剂的有效性和安全性。
{"title":"Review of the efficacy and safety of PCSK9 inhibitors in the therapy of lipid metabolism disorders","authors":"E. V. L. E. V. Lomakin","doi":"10.33920/med-03-2209-07","DOIUrl":"https://doi.org/10.33920/med-03-2209-07","url":null,"abstract":"Lipid metabolism disorder with a predominance of very-low-density lipoproteins (VLDL), triglycerides (TG), and cholesterol (CS) in the blood plasma contributes to the development of atherosclerotic diseases, which to date remain the main cause of death among the population, ranking first among all causes of death in the world and claiming the lives of 4 million Earth inhabitants every year. In this regard, there is a need to search for drugs that reduce the level of cholesterol, triglycerides, and VLDL in blood plasma. Such a group of drugs is PCSK9 inhibitors. Purpose of the study: to evaluate the efficacy and safety of the new class of lipid-lowering drugs — PCSK9 inhibitors.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131968730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real practice and work prospects of a clinical pharmacologist in an oncology dispensary 肿瘤科临床药理学家的实际实践与工作前景
Pub Date : 2022-08-31 DOI: 10.33920/med-03-2209-02
E. V. Paravina
On May 5, 1997, the order of the Ministry of Health of Russia No. 131 «On the Introduction of Clinical Pharmacology Major» entered into force. For a short period, clinical pharmacology has become not only an academic discipline and a scientific major, but one of the most sought-after applied areas. The World Health Organization has defined the main goal of clinical pharmacology as a practical major: «Improving patients’ health by increasing safe and effective use of medications». The clinical pharmacology service of the dispensary fully participates and plays one of the main roles in the process of ensuring the drug safety of a medical organization.
1997年5月5日,俄罗斯卫生部第131号命令《关于引进临床药理学专业》生效。在短时间内,临床药理学不仅成为一门学科和一门科学专业,而且成为最受欢迎的应用领域之一。世界卫生组织将临床药理学的主要目标定义为一门实用专业:“通过增加药物的安全和有效使用来改善患者的健康”。药房的临床药理服务是医疗机构在保障用药安全过程中充分参与和发挥主要作用的环节之一。
{"title":"Real practice and work prospects of a clinical pharmacologist in an oncology dispensary","authors":"E. V. Paravina","doi":"10.33920/med-03-2209-02","DOIUrl":"https://doi.org/10.33920/med-03-2209-02","url":null,"abstract":"On May 5, 1997, the order of the Ministry of Health of Russia No. 131 «On the Introduction of Clinical Pharmacology Major» entered into force. For a short period, clinical pharmacology has become not only an academic discipline and a scientific major, but one of the most sought-after applied areas. The World Health Organization has defined the main goal of clinical pharmacology as a practical major: «Improving patients’ health by increasing safe and effective use of medications». The clinical pharmacology service of the dispensary fully participates and plays one of the main roles in the process of ensuring the drug safety of a medical organization.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130488910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of digoxin testing in children with congenital heart defects 地高辛检测在先天性心脏缺陷患儿中的意义
Pub Date : 2022-08-31 DOI: 10.33920/med-03-2209-13
O. Petrova, D. K. Tverdokhlebova, D. Nikulina, S. Shashin, D. Tarasov
The purpose of the research is to study the significance of digoxin testing in children with congenital heart defects (CHD).
本研究旨在探讨地高辛检测在先天性心脏缺陷(CHD)患儿中的意义。
{"title":"Significance of digoxin testing in children with congenital heart defects","authors":"O. Petrova, D. K. Tverdokhlebova, D. Nikulina, S. Shashin, D. Tarasov","doi":"10.33920/med-03-2209-13","DOIUrl":"https://doi.org/10.33920/med-03-2209-13","url":null,"abstract":"The purpose of the research is to study the significance of digoxin testing in children with congenital heart defects (CHD).","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115607900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the efficacy and toxicity of chemotherapy for small-cell lung cancer in the Oncological Dispensary of the Voronezh Region 沃罗涅日地区肿瘤药房小细胞肺癌化疗的疗效和毒性评价
Pub Date : 2022-08-31 DOI: 10.33920/med-03-2209-10
E. A. Luneva
Small-cell lung cancer occupies a leading position in terms of incidence among all types of cancer, and the prevalence of this oncology worldwide increases by 0.5 % every year. These tumors grow rapidly and metastasize early. Therefore, effective pharmacotherapy of this pathology is relevant today. Purpose of the study: to analyze case histories of patients with small-cell lung cancer and compare treatment regimens to evaluate their ef ficacy and toxicit y.
在所有类型的癌症中,小细胞肺癌的发病率处于领先地位,全球范围内这种肿瘤的患病率每年增加0.5%。这些肿瘤生长迅速,转移早。因此,有效的药物治疗这种病理是相关的今天。本研究目的:分析小细胞肺癌患者的病例史,比较不同治疗方案的疗效和毒副作用。
{"title":"Evaluation of the efficacy and toxicity of chemotherapy for small-cell lung cancer in the Oncological Dispensary of the Voronezh Region","authors":"E. A. Luneva","doi":"10.33920/med-03-2209-10","DOIUrl":"https://doi.org/10.33920/med-03-2209-10","url":null,"abstract":"Small-cell lung cancer occupies a leading position in terms of incidence among all types of cancer, and the prevalence of this oncology worldwide increases by 0.5 % every year. These tumors grow rapidly and metastasize early. Therefore, effective pharmacotherapy of this pathology is relevant today. Purpose of the study: to analyze case histories of patients with small-cell lung cancer and compare treatment regimens to evaluate their ef ficacy and toxicit y.","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131185743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Glavvrač (Chief Medical Officer)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1